Compounds > 6-methoxy-8-(3-diethylaminopropylamino)quinoline
Page last updated: 2024-09-03

6-methoxy-8-(3-diethylaminopropylamino)quinoline and hydroxychloroquine

6-methoxy-8-(3-diethylaminopropylamino)quinoline has been researched along with hydroxychloroquine in 1 studies

Compound Research Comparison

Studies
(6-methoxy-8-(3-diethylaminopropylamino)quinoline)		Trials
(6-methoxy-8-(3-diethylaminopropylamino)quinoline)		Recent Studies (post-2010)
(6-methoxy-8-(3-diethylaminopropylamino)quinoline)		Studies
(hydroxychloroquine)		Trials
(hydroxychloroquine)		Recent Studies (post-2010) (hydroxychloroquine)
20005,8854744,041

Protein Interaction Comparison

ProteinTaxonomy6-methoxy-8-(3-diethylaminopropylamino)quinoline (IC50)hydroxychloroquine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)2.951
Alpha-1D adrenergic receptorHomo sapiens (human)4.772
Toll-like receptor 9Homo sapiens (human)0.11
Toll-like receptor 7Homo sapiens (human)3.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumamoto, T1

Reviews

1 review(s) available for 6-methoxy-8-(3-diethylaminopropylamino)quinoline and hydroxychloroquine

ArticleYear
[Amphiphilic cationic drug myopathy, drug-induced lysosomal storage lipidosis].
    Ryoikibetsu shokogun shirizu, 2001, Issue:36

    Topics: Aminoquinolines; Amiodarone; Animals; Anti-Arrhythmia Agents; Antimalarials; Autophagy; Cations; Chloroquine; Diagnosis, Differential; Humans; Hydroxychloroquine; Lysosomes; Muscle, Skeletal; Muscular Diseases; Perhexiline; Prognosis; Vacuoles

2001